Corporate Profile

inVentiv Health (NASDAQ: VTIV) is the leading provider of commercialization services to the global pharmaceutical and life sciences industries. inVentiv's employees support over 350 client organizations, including all top 20 global pharmaceutical companies as well as emerging and specialty biotech leaders.

The inVentiv delivery model is flexible and client-focused, enabling the company to rapidly respond to changing client needs and market conditions with both integrated and independent programs.

inVentiv's customized clinical, sales, marketing and communications services are organized into four key business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes:

inVentiv Clinical

• Clinical Staffing
• Clinical Development
• Strategic Resource Groups
• Executive Placement

inVentiv Communications

• Advertising
• Branding
• Interactive Communication
• Medical Education
• Public Relations

inVentiv Commercial

• Strategic Planning
• Market Analytics & Research
• Marketing Segmentation
• Access Strategy
• Sales Teams
• Training & Development
• Sales Recruitment
• Sample Management
• ePromotion

inVentiv Patient Outcomes

• Patient Adherence
• Patient Assistance
• Clinical Educator Teams
• Disease Management
• Patient Relationship Management

In 2007, inVentiv reported revenues of $977 million, which represents an increase of 28% from 2006 results, and adjusted net earnings per share from continuing operations of $1.59 (GAAP of $1.46), which represents an increase of 16% over 2006 results (GAAP EPS down 11% due to 2006 tax benefits). As of December 31, 2007, the Company had $1.1 billion in total assets, including $98 million of cash and marketable securities on the Balance Sheet. inVentiv Health, a component of the Russell 3000 and the S&P SmallCap 600, is listed on the NASDAQ National Market under the symbol "VTIV."